Peter Wm Kronen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Peter Wm Kronen has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Karina Klein
Musculoskeletal Research Unit, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
8 shared publications - Brigitte von Rechenberg
Musculoskeletal Research Unit, Equine Hospital, Vetsuisse Faculty ZH, University of Zurich, Zurich, Switzerland
6 shared publications - Katja Nuss
University of Zürich, Musculoskeletal Research Unit, Zürich
4 shared publications - Daniel Andermatt
Synthes GmbH, Luzernstrasse 21, 4528 Zuchwil/Solothurn, Switzerland. address for D. Andermatt:. address for R. Frigg:
3 shared publications - Henning Richter
Diagnostic Imaging Research Unit (DIRU), Clinic for Diagnostic Imaging, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
3 shared publications - Stephen J. Ferguson
Future Health Technologies, Singapore-ETH Centre, Campus for Research Excellence And Technological Enterprise (CREATE)
3 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Elsevier in Materials Today Communications
- Vol. 57
Novel purified clinoptilolite-tuff-doped alginate hemostatic dressing demonstrating rapid hemostasis and favorable safety profile
- 30 September 2026
- Published by Elsevier in Materials Today Communications
- Vol. 57
Open AccessNovel purified clinoptilolite-tuff-doped alginate hemostatic dressing demonstrating rapid hemostasis and favorable safety profile
- Open Access
- 21 September 2026
- Published by Wiley in Journal of Small Animal Practice
N ‐methyl‐ D ‐aspartate receptor antagonists for controlling pain in dogs
This is a mini review published by the World Small Animal Veterinary Association's Pain Committee. This article provides an assessment of the scientific evidence of N ‐methyl‐ d ‐aspartate receptor antagonists for controlling pain in dogs while identifying current knowledge gaps. The pathophysiology of chronic pain related to the N ‐methyl‐ d ‐aspartate receptor is reviewed, followed by the clinical application of some drugs in this class in clinical practice, with suggested dosage regimens. N ‐methyl‐D‐aspartate receptor antagonists are an attractive group of drugs to manage long‐standing pain because of the pivotal role of the N ‐methyl‐ d ‐aspartate receptor in central sensitisation and upregulation of pain pathways. More studies are needed to support the use of these drugs perioperatively and for treatment of chronic pain. Currently, information on best dosage regimens, safety, efficacy and which painful conditions can be targeted is lacking.
- 21 September 2026
- Published by Wiley in Journal of Small Animal Practice
Open AccessN ‐methyl‐ D ‐aspartate receptor antagonists for controlling pain in dogs
This is a mini review published by the World Small Animal Veterinary Association's Pain Committee. This article provides an assessment of the scientific evidence of N ‐methyl‐ d ‐aspartate receptor antagonists for controlling pain in dogs while identifying current knowledge gaps. The pathophysiology of chronic pain related to the N ‐methyl‐ d ‐aspartate receptor is reviewed, followed by the clinical application of some drugs in this class in clinical practice, with suggested dosage regimens. N ‐methyl‐D‐aspartate receptor antagonists are an attractive group of drugs to manage long‐standing pain because of the pivotal role of the N ‐methyl‐ d ‐aspartate receptor in central sensitisation and upregulation of pain pathways. More studies are needed to support the use of these drugs perioperatively and for treatment of chronic pain. Currently, information on best dosage regimens, safety, efficacy and which painful conditions can be targeted is lacking.
- Open Access
- 11 March 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1)
Safety and efficacy of the polymer enhanced AS-ELARIS® pedicle screw system using ultrasonically liquefied polylactide: a short-, mid-, and long-term posterolateral fusion study in sheep
Lumbar fusion surgery using pedicle screws and intervertebral cages is frequently performed to treat low back pain when conservative therapies were unsuccessful. Screw loosening, however, remains one of the most common postoperative complications. The purpose of this study was to show that the fixation with polymer-enhanced AS-ELARIS® Pedicle Screws by ultrasonic-assisted extrusion of 0.104 mL resorbable polylactide per screw, represents a suitable alternative to current fixation techniques. Forty adult female sheep were enrolled in the study and posterolateral fusions were performed at two non-adjacent lumbar levels (L1+L2, L4+L5), implanting eight AS-ELARIS® Pedicle Screws per animal. After a survival period of 2 days, 8 weeks, 6, 12 or 24 months, animals were sacrificed and the instrumented vertebrae harvested for macroscopic, radiological, and histological evaluation. Despite surgical challenges in achieving optimal screw positioning, all evaluations demonstrated good biocompatibility and progressive osseointegration. Ultrasonic liquefaction-mediated polymer enhancement proved safe at all investigated timepoints, without evidence of thermal or inflammatory tissue damage. The AS-ELARIS® Pedicle Screw System may offer a promising alternative to current fixation techniques. Its biocompatibility, biodegradability, safe removal, and ease of handling make it a valuable addition to spinal fixation strategies.
- 11 March 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1)
Open AccessSafety and efficacy of the polymer enhanced AS-ELARIS® pedicle screw system using ultrasonically liquefied polylactide: a short-, mid-, and long-term posterolateral fusion study in sheep
Lumbar fusion surgery using pedicle screws and intervertebral cages is frequently performed to treat low back pain when conservative therapies were unsuccessful. Screw loosening, however, remains one of the most common postoperative complications. The purpose of this study was to show that the fixation with polymer-enhanced AS-ELARIS® Pedicle Screws by ultrasonic-assisted extrusion of 0.104 mL resorbable polylactide per screw, represents a suitable alternative to current fixation techniques. Forty adult female sheep were enrolled in the study and posterolateral fusions were performed at two non-adjacent lumbar levels (L1+L2, L4+L5), implanting eight AS-ELARIS® Pedicle Screws per animal. After a survival period of 2 days, 8 weeks, 6, 12 or 24 months, animals were sacrificed and the instrumented vertebrae harvested for macroscopic, radiological, and histological evaluation. Despite surgical challenges in achieving optimal screw positioning, all evaluations demonstrated good biocompatibility and progressive osseointegration. Ultrasonic liquefaction-mediated polymer enhancement proved safe at all investigated timepoints, without evidence of thermal or inflammatory tissue damage. The AS-ELARIS® Pedicle Screw System may offer a promising alternative to current fixation techniques. Its biocompatibility, biodegradability, safe removal, and ease of handling make it a valuable addition to spinal fixation strategies.
- 26 November 2025
- Published by SAGE Publications in Laboratory Animals
- Vol. 60 (1) , 75-84
Clinical evaluation of intranasal midazolam and alfaxalone for induction of anaesthesia in rabbits
The aim of this experimental, descriptive study was to evaluate feasibility, safety and side effects of alfaxalone and midazolam by intranasal instillation for anaesthesia induction in rabbits. We included 26, healthy, female New Zealand White Rabbits undergoing general anaesthesia in context of a study to test different coatings for stifle joint endoprosthesis. Midazolam (0.1 mg/kg) and alfaxalone 3 mg/kg (group 1) or 4 mg/kg (group 2) were mixed and administered intranasally. The number of sneezes, swallows and evasive attempts were recorded. Time to lateral recumbency, presence of salivation, nystagmus, induction and intubation qualities were scored. If intubation was not possible, a top-up of 1 mg/kg alfaxalone was administered intranasally. If still not sufficient, anaesthesia was induced by mask-insufflation of isoflurane. Data were analysed using IBM SPSS Statistics 30.0.0.0 and non-parametric data compared using either a Mann–Whitney test or a chi-square test. Overall, 10 animals assigned to group 1 and 16 animals to group 2 were included in the study. In 24/26 rabbits (92.3%) no significant complications were noted. One rabbit showed 20 s of apnoea after induction and one rabbit died during induction. Top-up dosages of alfaxalone were necessary in three cases and in two of these three, isoflurane administration was also required to complete anaesthetic induction. The median time to lateral recumbency was 32.5 s in group 1 and 15 s in group 2. By intranasal application of midazolam with alfaxalone at both dosages, the anaesthetic state was induced shortly after application.
- 26 November 2025
- Published by SAGE Publications in Laboratory Animals
- Vol. 60 (1) , 75-84
Clinical evaluation of intranasal midazolam and alfaxalone for induction of anaesthesia in rabbits
The aim of this experimental, descriptive study was to evaluate feasibility, safety and side effects of alfaxalone and midazolam by intranasal instillation for anaesthesia induction in rabbits. We included 26, healthy, female New Zealand White Rabbits undergoing general anaesthesia in context of a study to test different coatings for stifle joint endoprosthesis. Midazolam (0.1 mg/kg) and alfaxalone 3 mg/kg (group 1) or 4 mg/kg (group 2) were mixed and administered intranasally. The number of sneezes, swallows and evasive attempts were recorded. Time to lateral recumbency, presence of salivation, nystagmus, induction and intubation qualities were scored. If intubation was not possible, a top-up of 1 mg/kg alfaxalone was administered intranasally. If still not sufficient, anaesthesia was induced by mask-insufflation of isoflurane. Data were analysed using IBM SPSS Statistics 30.0.0.0 and non-parametric data compared using either a Mann–Whitney test or a chi-square test. Overall, 10 animals assigned to group 1 and 16 animals to group 2 were included in the study. In 24/26 rabbits (92.3%) no significant complications were noted. One rabbit showed 20 s of apnoea after induction and one rabbit died during induction. Top-up dosages of alfaxalone were necessary in three cases and in two of these three, isoflurane administration was also required to complete anaesthetic induction. The median time to lateral recumbency was 32.5 s in group 1 and 15 s in group 2. By intranasal application of midazolam with alfaxalone at both dosages, the anaesthetic state was induced shortly after application.
- Open Access
- 14 January 2025
- Published by MDPI AG in Brain Sciences
- Vol. 15 (1) , 69
Normative Values of Brainstem Auditory-Evoked Responses in Sheep
Background: The brainstem auditory-evoked response (BAER) is an established electrophysiological measure of neural activity from the auditory nerve up to the brain stem. The BAER is used to diagnose abnormalities in auditory pathways and in neurophysiological human and animal research. However, normative data for BAERs in sheep, which represent an adequate large animal model for translational and basic otological research, are lacking. Objective: The aim of this study was to assess the function of the ovine auditory nervous system by determining normative values for the BAER and to compare sheep with human BAER data. Methods: In this retrospective study, BAER data for click stimuli at a range of sound pressure levels (SPLs) were analyzed. A series of 15 samples from six sheep with a mean age of 41.8 months was included. Results: The mean BAER threshold was 45.3 dB SPL. At 100 dB SPL, the mean (±standard deviation, SD) latency of wave V was 4.35 (±0.18) ms, that of wave III was 2.44 (±0.15) ms, and that of wave I was 0.88 (±0.13) ms. At 100 dB SPL, the mean interpeak latency of waves I–III was 1.56 (±0.18) ms, that of waves III–V was 1.91 (±0.16) ms, and that of waves I–V was 3.47 (±0.20) ms. The mean amplitudes at 100 dB SPL were 0.04 (±0.03) µV for wave I, 0.50 (±0.24) µV for wave III, and 0.40 (±0.25) µV for wave V. Conclusions: The normative values for sheep BAERs were reproducible and similar to those of humans. The normative BAER values further support sheep as an adequate animal model for otological research.
- 14 January 2025
- Published by MDPI AG in Brain Sciences
- Vol. 15 (1) , 69
Open AccessNormative Values of Brainstem Auditory-Evoked Responses in Sheep
Background: The brainstem auditory-evoked response (BAER) is an established electrophysiological measure of neural activity from the auditory nerve up to the brain stem. The BAER is used to diagnose abnormalities in auditory pathways and in neurophysiological human and animal research. However, normative data for BAERs in sheep, which represent an adequate large animal model for translational and basic otological research, are lacking. Objective: The aim of this study was to assess the function of the ovine auditory nervous system by determining normative values for the BAER and to compare sheep with human BAER data. Methods: In this retrospective study, BAER data for click stimuli at a range of sound pressure levels (SPLs) were analyzed. A series of 15 samples from six sheep with a mean age of 41.8 months was included. Results: The mean BAER threshold was 45.3 dB SPL. At 100 dB SPL, the mean (±standard deviation, SD) latency of wave V was 4.35 (±0.18) ms, that of wave III was 2.44 (±0.15) ms, and that of wave I was 0.88 (±0.13) ms. At 100 dB SPL, the mean interpeak latency of waves I–III was 1.56 (±0.18) ms, that of waves III–V was 1.91 (±0.16) ms, and that of waves I–V was 3.47 (±0.20) ms. The mean amplitudes at 100 dB SPL were 0.04 (±0.03) µV for wave I, 0.50 (±0.24) µV for wave III, and 0.40 (±0.25) µV for wave V. Conclusions: The normative values for sheep BAERs were reproducible and similar to those of humans. The normative BAER values further support sheep as an adequate animal model for otological research.
- Open Access
Blood oxygenation-level dependent cerebrovascular reactivity imaging as strategy to monitor CSF-hemoglobin toxicity
Purpose Cell-free hemoglobin in the cerebrospinal fluid (CSF-Hb) may be one of the main drivers of secondary brain injury after aneurysmal subarachnoid hemorrhage. Haptoglobin scavenging of CSF-Hb has been shown to mitigate cerebrovascular disruption. Using digital subtraction angiography (DSA) and blood oxygenation-level dependent cerebrovascular reactivity imaging (BOLD-CVR) the aim was to assess the acute toxic effect of CSF-Hb on cerebral blood flow and autoregulation, as well as to test the protective effects of haptoglobin. Methods DSA imaging was performed in eight anesthetized and ventilated sheep (mean weight: 80.4 kg) at baseline, 15, 30, 45 and 60 minutes after infusion of hemoglobin (Hb) or co-infusion with haptoglobin (Hb:Haptoglobin) into the left lateral ventricle. Additionally, 10 ventilated sheep (mean weight: 79.8 kg) underwent BOLD-CVR imaging to assess the cerebrovascular reserve capacity. Results DSA imaging did not show a difference in mean transit time or cerebral blood flow. Wholebrain BOLD-CVR compared to baseline decreased more in the Hb group after 15 minutes (Hb vs Hb:Haptoglobin: −0.03 ±0.01 vs −0.01 ±0.02) and remained diminished compared to Hb:Haptoglobin group after 30 minutes (Hb vs Hb:Haptoglobin: −0.03 ±0.01 vs 0.0 ±0.01), 45 minutes (Hb vs Hb:Haptoglobin: −0.03 ±0.01 vs 0.01 ±0.02) and 60 minutes (Hb vs Hb:Haptoglobin: −0.03 ±0.02 vs 0.01 ±0.01). Conclusion It is demonstrated that CSF-Hb toxicity leads to rapid cerebrovascular reactivity impairment, which is blunted by haptoglobin co-infusion. BOLD-CVR may therefore be further evaluated as a monitoring strategy for CSF-Hb toxicity after aSAH.
Open AccessBlood oxygenation-level dependent cerebrovascular reactivity imaging as strategy to monitor CSF-hemoglobin toxicity
Purpose Cell-free hemoglobin in the cerebrospinal fluid (CSF-Hb) may be one of the main drivers of secondary brain injury after aneurysmal subarachnoid hemorrhage. Haptoglobin scavenging of CSF-Hb has been shown to mitigate cerebrovascular disruption. Using digital subtraction angiography (DSA) and blood oxygenation-level dependent cerebrovascular reactivity imaging (BOLD-CVR) the aim was to assess the acute toxic effect of CSF-Hb on cerebral blood flow and autoregulation, as well as to test the protective effects of haptoglobin. Methods DSA imaging was performed in eight anesthetized and ventilated sheep (mean weight: 80.4 kg) at baseline, 15, 30, 45 and 60 minutes after infusion of hemoglobin (Hb) or co-infusion with haptoglobin (Hb:Haptoglobin) into the left lateral ventricle. Additionally, 10 ventilated sheep (mean weight: 79.8 kg) underwent BOLD-CVR imaging to assess the cerebrovascular reserve capacity. Results DSA imaging did not show a difference in mean transit time or cerebral blood flow. Wholebrain BOLD-CVR compared to baseline decreased more in the Hb group after 15 minutes (Hb vs Hb:Haptoglobin: −0.03 ±0.01 vs −0.01 ±0.02) and remained diminished compared to Hb:Haptoglobin group after 30 minutes (Hb vs Hb:Haptoglobin: −0.03 ±0.01 vs 0.0 ±0.01), 45 minutes (Hb vs Hb:Haptoglobin: −0.03 ±0.01 vs 0.01 ±0.02) and 60 minutes (Hb vs Hb:Haptoglobin: −0.03 ±0.02 vs 0.01 ±0.01). Conclusion It is demonstrated that CSF-Hb toxicity leads to rapid cerebrovascular reactivity impairment, which is blunted by haptoglobin co-infusion. BOLD-CVR may therefore be further evaluated as a monitoring strategy for CSF-Hb toxicity after aSAH.
- Open Access
- 3 April 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (4) , 380
Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation
Tendon defects require multimodal therapeutic management over extensive periods and incur high collateral burden with frequent functional losses. Specific cell therapies have recently been developed in parallel to surgical techniques for managing acute and degenerative tendon tissue affections, to optimally stimulate resurgence of structure and function. Cultured primary human fetal progenitor tenocytes (hFPT) have been preliminarily considered for allogeneic homologous cell therapies, and have been characterized as stable, consistent, and sustainable cell sources in vitro. Herein, optimized therapeutic cell sourcing from a single organ donation, industrial transposition of multi-tiered progenitor cell banking, and preliminary preclinical safety of an established hFPT cell source (i.e., FE002-Ten cell type) were investigated. Results underlined high robustness of FE002-Ten hFPTs and suitability for sustainable manufacturing upscaling within optimized biobanking workflows. Absence of toxicity or tumorigenicity of hFPTs was demonstrated in ovo and in vitro, respectively. Furthermore, a 6-week pilot good laboratory practice (GLP) safety study using a rabbit patellar tendon partial-thickness defect model preliminarily confirmed preclinical safety of hFPT-based standardized transplants, wherein no immune reactions, product rejection, or tumour formation were observed. Such results strengthen the rationale of the multimodal Swiss fetal progenitor cell transplantation program and prompt further investigation around such cell sources in preclinical and clinical settings for musculoskeletal regenerative medicine.
- 3 April 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (4) , 380
Open AccessIndustrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation
Tendon defects require multimodal therapeutic management over extensive periods and incur high collateral burden with frequent functional losses. Specific cell therapies have recently been developed in parallel to surgical techniques for managing acute and degenerative tendon tissue affections, to optimally stimulate resurgence of structure and function. Cultured primary human fetal progenitor tenocytes (hFPT) have been preliminarily considered for allogeneic homologous cell therapies, and have been characterized as stable, consistent, and sustainable cell sources in vitro. Herein, optimized therapeutic cell sourcing from a single organ donation, industrial transposition of multi-tiered progenitor cell banking, and preliminary preclinical safety of an established hFPT cell source (i.e., FE002-Ten cell type) were investigated. Results underlined high robustness of FE002-Ten hFPTs and suitability for sustainable manufacturing upscaling within optimized biobanking workflows. Absence of toxicity or tumorigenicity of hFPTs was demonstrated in ovo and in vitro, respectively. Furthermore, a 6-week pilot good laboratory practice (GLP) safety study using a rabbit patellar tendon partial-thickness defect model preliminarily confirmed preclinical safety of hFPT-based standardized transplants, wherein no immune reactions, product rejection, or tumour formation were observed. Such results strengthen the rationale of the multimodal Swiss fetal progenitor cell transplantation program and prompt further investigation around such cell sources in preclinical and clinical settings for musculoskeletal regenerative medicine.
- 1 September 2019
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 80 (9) , 832-839
Diffusion-weighted and perfusion-weighted magnetic resonance imaging of the prostate gland of healthy adult dogs
OBJECTIVE: To describe diffusion and perfusion characteristics of the prostate gland of healthy sexually intact adult dogs as determined by use of diffusion-weighted and perfusion-weighted MRI. ANIMALS: 12 healthy sexually intact adult Beagles. PROCEDURES: Ultrasonography of the prostate gland was performed. Subsequently, each dog was anesthetized, and morphological, diffusion-weighted, and perfusion-weighted MRI of the caudal aspect of the abdomen was performed. The apparent diffusion coefficient was calculated for the prostate gland parenchyma in diffusion-weighted MRI images in the central ventral and peripheral dorsal areas. Perfusion variables were examined in multiple regions of interest (ROIs) in the ventral and dorsal areas of the prostate gland and in the gluteal musculature. Signal intensity was determined, and a time-intensity curve was generated for each ROI. RESULTS: Results of ultrasonographic examination of the prostate gland revealed no abnormalities for any dog. Median apparent diffusion coefficient of the prostate gland was 1.51 × 10−3 mm2/s (range, 1.04 × 10−3 mm2/s to 1.86 × 10−3 mm2/s). Perfusion-weighted MRI variables for the ROIs differed between the prostate gland parenchyma and gluteal musculature. CONCLUSIONS AND CLINICAL RELEVANCE: Results provided baseline information about diffusion and perfusion characteristics of the prostate gland in healthy sexually intact adult dogs. Additional studies with dogs of various ages and breeds, with and without abnormalities of the prostate gland, will be necessary to validate these findings and investigate clinical applications.
- 1 September 2019
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 80 (9) , 832-839
Diffusion-weighted and perfusion-weighted magnetic resonance imaging of the prostate gland of healthy adult dogs
OBJECTIVE: To describe diffusion and perfusion characteristics of the prostate gland of healthy sexually intact adult dogs as determined by use of diffusion-weighted and perfusion-weighted MRI. ANIMALS: 12 healthy sexually intact adult Beagles. PROCEDURES: Ultrasonography of the prostate gland was performed. Subsequently, each dog was anesthetized, and morphological, diffusion-weighted, and perfusion-weighted MRI of the caudal aspect of the abdomen was performed. The apparent diffusion coefficient was calculated for the prostate gland parenchyma in diffusion-weighted MRI images in the central ventral and peripheral dorsal areas. Perfusion variables were examined in multiple regions of interest (ROIs) in the ventral and dorsal areas of the prostate gland and in the gluteal musculature. Signal intensity was determined, and a time-intensity curve was generated for each ROI. RESULTS: Results of ultrasonographic examination of the prostate gland revealed no abnormalities for any dog. Median apparent diffusion coefficient of the prostate gland was 1.51 × 10−3 mm2/s (range, 1.04 × 10−3 mm2/s to 1.86 × 10−3 mm2/s). Perfusion-weighted MRI variables for the ROIs differed between the prostate gland parenchyma and gluteal musculature. CONCLUSIONS AND CLINICAL RELEVANCE: Results provided baseline information about diffusion and perfusion characteristics of the prostate gland in healthy sexually intact adult dogs. Additional studies with dogs of various ages and breeds, with and without abnormalities of the prostate gland, will be necessary to validate these findings and investigate clinical applications.
- 1 February 2015
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 97 (3) , 208-215
Dynamization at the Near Cortex in Locking Plate Osteosynthesis by Means of Dynamic Locking Screws
Ffect on bone-healing of dynamization of locking plate constructs by means of new 5.0-mm dynamic locking screws (in the DLS group), which allow near-cortex micromotion, compared with a more rigid construct utilizing standard bicortical locking-head screws (in the LS group). Use of dynamic locking screws allows modulation of the stiffness of existing locking compression plate systems via parallel interfragmentary micromotion. Methods: A standardized diaphyseal tibial osteotomy (90°, 3-mm fracture gap) was performed and stabilized with a six-hole large-fragment locking compression plate in twelve female sheep (six in each group). Radiographs were made postoperatively and then weekly from week three until sacrifice at nine weeks. Macroscopic, biomechanical, histologic, and radiographic assessments and microcomputed tomography were performed. Results: The callus in the tested specimens in the DLS group had better biomechanical stability, with a significantly greater maximum failure moment (mean and standard deviation [SD] as a percentage of intact, 55.15 ± 20.65 compared with 26.80 ± 14.96 in the LS group; p = 0.021). The DLS group also had greater periosteal callus volume at the near cortex (mean volume and SD as a percentage of the tibial shaft volume, 36.21% ± 10.08% compared with 18.98% ± 8.61% in the LS group; p = 0.026) and in the intercortical region (mean volume and SD as a percentage of the bone volume of the tibial shaft, 3.56% ± 0.52% compared with 2.64% ± 0.98% in the LS group; p = 0.045), as shown by microcomputed tomography. The DLS group also had significantly greater torsional stiffness (mean and SD as a percentage of intact, 84.88 ± 13.51 compared with 58.89 ± 20.61 in the LS group; p = 0.027). Conclusions: Controlled micromotion and nearly homogeneous interfragmentary strain at the fracture site, together with the stable bicortical fixation achieved by the new dynamic locking screw, led to more uniform callus formation, significantly more callus formation at the near cortex, and biomechanically more competent bone-healing compared with use of rigid locking plate constructs with locking-head screws....
- 1 February 2015
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 97 (3) , 208-215
Dynamization at the Near Cortex in Locking Plate Osteosynthesis by Means of Dynamic Locking Screws
Ffect on bone-healing of dynamization of locking plate constructs by means of new 5.0-mm dynamic locking screws (in the DLS group), which allow near-cortex micromotion, compared with a more rigid construct utilizing standard bicortical locking-head screws (in the LS group). Use of dynamic locking screws allows modulation of the stiffness of existing locking compression plate systems via parallel interfragmentary micromotion. Methods: A standardized diaphyseal tibial osteotomy (90°, 3-mm fracture gap) was performed and stabilized with a six-hole large-fragment locking compression plate in twelve female sheep (six in each group). Radiographs were made postoperatively and then weekly from week three until sacrifice at nine weeks. Macroscopic, biomechanical, histologic, and radiographic assessments and microcomputed tomography were performed. Results: The callus in the tested specimens in the DLS group had better biomechanical stability, with a significantly greater maximum failure moment (mean and standard deviation [SD] as a percentage of intact, 55.15 ± 20.65 compared with 26.80 ± 14.96 in the LS group; p = 0.021). The DLS group also had greater periosteal callus volume at the near cortex (mean volume and SD as a percentage of the tibial shaft volume, 36.21% ± 10.08% compared with 18.98% ± 8.61% in the LS group; p = 0.026) and in the intercortical region (mean volume and SD as a percentage of the bone volume of the tibial shaft, 3.56% ± 0.52% compared with 2.64% ± 0.98% in the LS group; p = 0.045), as shown by microcomputed tomography. The DLS group also had significantly greater torsional stiffness (mean and SD as a percentage of intact, 84.88 ± 13.51 compared with 58.89 ± 20.61 in the LS group; p = 0.027). Conclusions: Controlled micromotion and nearly homogeneous interfragmentary strain at the fracture site, together with the stable bicortical fixation achieved by the new dynamic locking screw, led to more uniform callus formation, significantly more callus formation at the near cortex, and biomechanically more competent bone-healing compared with use of rigid locking plate constructs with locking-head screws....